TIG Advisors »

Gracell Biotechnologies shares owned by TIG Advisors

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by TIG Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 1.3M 10.04

More positions owned by TIG Advisors

United States Steel Corporation Put Option (X)
Capri Holdings SHS (CPRI)
stock
ImmunoGen
Ansys Call Option (ANSS)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Pioneer Natural Resources (PXD)
Albertsons Cos Common Stock Put Option (ACI)
Cleveland-cliffs (CLF)
Chevron Corporation (CVX)
Cytokinetics Com New Call Option (CYTK)
Argenx Se Sponsored Adr Call Option (ARGX)
Apellis Pharmaceuticals (APLS)
Gracell Biotechnologies Sponsored Ads
Neurocrine Biosciences Call Option (NBIX)

View all positions for TIG Advisors

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies